Novel mGluR4 agonist Rapitalam ameliorates motor dysfunction in mice with tau-associated neurodegeneration.Published in:Research Results in Pharmacology, 2020, v. 6, n. 2, p. 9, doi. 10.3897/rrpharmacology.6.52098By:Avdeeva, Natalia V.Publication type:Article